Occult macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis

被引:5
|
作者
Behrens, Edward M.
Beukelman, Timothy
Paessler, Michele
Cron, Randy Q.
机构
[1] Childrens Hosp, Dept Pediat, Div Rheumatol, Philadelphia, PA 19104 USA
[2] Childrens Hosp, Dept Pathol, Philadelphia, PA 19104 USA
[3] Univ Penn, Sch Med, Philadelphia, PA 19104 USA
关键词
macrophage activation syndrome; systemic juvenile idiopathic arthritis; hemophagocytosis; CD163; antigen; bone marrow aspirate; hemophagocytic lymphohistiocytosis;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. Macrophage activation syndrome (MAS) is a well described, but purportedly uncommon manifestation of systemic juvenile idiopathic arthritis (SJIA). There is evidence to suggest that macrophage activation is integral to the pathogenesis of SJIA, Accordingly, many patients with SJIA may have evidence of mild MAS that is not appreciated clinically. We investigated the prevalence of occult MAS in children with SJIA by reviewing bone marrow aspirates (BMA). Methods. Patients diagnosed with SJIA who underwent bone marrow aspiration were identified retrospectively. Patients admitted with a diagnosis of fever of unknown origin and discharged with a diagnosis other than SJIA or malignancy, and who had a BMA, were identified as controls. The BMA were reviewed by a single hematopathologist for evidence of MAS, ranging from activated macrophages to frank hemophagocytic cells. Results. Eight of 15 (53%) patients with SJIA had BMA suggestive of MAS. Two of 15 patients (13%) were diagnosed clinically with MAS. Three patients (20%) were noted to have frank hemophagocytosis, only one of whom was diagnosed with MAS clinically. There were no statistically significant differences in the laboratory values for the patients with and without evidence of MAS on BMA. There was no evidence of increased macrophage activity or hemophagocytosis in any of the control BMA. Conclusion. Occult MAS appears to be common in patients with SJIA who undergo BMA. This suggests that macrophage activation may be integral to the pathogenesis of SJIA, with implications for treatment.
引用
收藏
页码:1133 / 1138
页数:6
相关论文
共 50 条
  • [31] Standard and increased canakinumab dosing to quiet macrophage activation syndrome in children with systemic juvenile idiopathic arthritis
    Kostik, Mikhail M.
    Isupova, Eugenia A.
    Belozerov, Konstantin
    Likhacheva, Tatyana S.
    Suspitsin, Evgeny N.
    Raupov, Rinat
    Masalova, Vera V.
    Chikova, Irina A.
    Dubko, Margarita F.
    Kalashnikova, Olga V.
    Chasnyk, Vyacheslav G.
    Cron, Randy Q.
    FRONTIERS IN PEDIATRICS, 2022, 10
  • [32] Mutations in the perforin gene can be linked to macrophage activation syndrome in patients with systemic onset juvenile idiopathic arthritis
    Vastert, Sebastiaan J.
    van Wijk, Richard
    D'Urbano, Leila E.
    de Vooght, Karen M. K.
    de Jager, Wilco
    Ravelli, Angelo
    Magni-Manzoni, Silvia
    Insalaco, Antonella
    Cortis, Elisabetta
    van Solinge, Wouter W.
    Prakken, Berent J.
    Wulffraat, Nico M.
    de Benedetti, Fabrizio
    Kuis, Wietse
    RHEUMATOLOGY, 2010, 49 (03) : 441 - 449
  • [33] Performances of the "MS-score" And "HScore" in the diagnosis of macrophage activation syndrome in systemic juvenile idiopathic arthritis patients
    Sag, Erdal
    Keskin, Armagan
    Atalay, Erdal
    Demir, Selcan
    Cuceoglu, Muserref Kasap
    Akca, Ummusen Kaya
    Batu, Ezgi Deniz
    Bilginer, Yelda
    Ozen, Seza
    RHEUMATOLOGY INTERNATIONAL, 2021, 41 (01) : 87 - 93
  • [34] Performances of the “MS-score” And “HScore” in the diagnosis of macrophage activation syndrome in systemic juvenile idiopathic arthritis patients
    Erdal Sag
    Armagan Keskin
    Erdal Atalay
    Selcan Demir
    Muserref Kasap Cuceoglu
    Ummusen Kaya Akca
    Ezgi Deniz Batu
    Yelda Bilginer
    Seza Ozen
    Rheumatology International, 2021, 41 : 87 - 93
  • [35] Evidence-based diagnosis and treatment of macrophage activation syndrome in systemic juvenile idiopathic arthritis
    Boom, V.
    Anton, J.
    Lahdenne, P.
    Quartier, P.
    Ravelli, A.
    Wulffraat, N. M.
    Vastert, S. J.
    PEDIATRIC RHEUMATOLOGY, 2015, 13
  • [36] Interleukin-18 for predicting the development of macrophage activation syndrome in systemic juvenile idiopathic arthritis
    Shimizu, Masaki
    Nakagishi, Yasuo
    Inoue, Natsumi
    Mizuta, Mao
    Ko, Giyo
    Saikawa, Yutaka
    Kubota, Tomohiro
    Yamasaki, Yuichi
    Takei, Syuji
    Yachie, Akihiro
    CLINICAL IMMUNOLOGY, 2015, 160 (02) : 277 - 281
  • [37] The dynamics of laboratory markers reflecting cytokine overproduction in macrophage activation syndrome complicated with systemic juvenile idiopathic arthritis
    Kaneko, Shuya
    Shimizu, Masaki
    Miyaoka, Futaba
    Shimbo, Asami
    Irabu, Hitoshi
    Mizuta, Mao
    Nakagishi, Yasuo
    Iwata, Naomi
    Fujimura, Junya
    Mori, Masaaki
    Morio, Tomohiro
    CLINICAL IMMUNOLOGY, 2023, 248
  • [38] Evidence-based diagnosis and treatment of macrophage activation syndrome in systemic juvenile idiopathic arthritis
    V. Boom
    J. Anton
    P. Lahdenne
    P. Quartier
    A. Ravelli
    N.M. Wulffraat
    S.J. Vastert
    Pediatric Rheumatology, 13
  • [39] Hepatitis A-associated macrophage activation syndrome in children with systemic juvenile idiopathic arthritis: Report of 2 cases
    Russo, Ricardo A. G.
    Rosenzweig, Sergio D.
    Katsicas, Maria M.
    JOURNAL OF RHEUMATOLOGY, 2008, 35 (01) : 166 - 168
  • [40] Rapid and Sustained Remission of Systemic Juvenile Idiopathic Arthritis-Associated Macrophage Activation Syndrome Through Treatment With Anakinra and Corticosteroids
    Bruck, Normi
    Suttorp, Meinolf
    Kabus, Maria
    Heubner, Georg
    Gahr, Manfred
    Pessler, Frank
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2011, 17 (01) : 23 - 27